Innovation in Digital Education: Lessons Learned from the Multiple Sclerosis Management Master's Program
- PMID: 34439729
- PMCID: PMC8393651
- DOI: 10.3390/brainsci11081110
Innovation in Digital Education: Lessons Learned from the Multiple Sclerosis Management Master's Program
Abstract
Since 2020, the master's program "Multiple Sclerosis Management" has been running at Dresden International University, offering structured training to become a multiple sclerosis specialist. Due to the COVID-19 pandemic, many planned teaching formats had to be changed to online teaching. The subject of this paper was the investigation of a cloud-based digital hub and student evaluation of the program. Authors analyzed use cases of computer-supported collaborative learning and student evaluation of courses and modules using the Gioia method and descriptive statistics. The use of a cloud-based digital hub as a central data platform proved to be highly successful for learning and teaching, as well as for close interaction between lecturers and students. Students rated the courses very positively in terms of content, knowledge transfer and interaction. The implementation of the master's program was successful despite the challenges of the COVID-19 pandemic. The resulting extensive use of digital tools demonstrates the "new normal" of future learning, with even more emphasis on successful online formats that also increase interaction between lecturers and students in particular. At the same time, there will continue to be tailored face-to-face events to specifically increase learning success.
Keywords: Dresden International University; digitization; education; master’s program; multiple sclerosis; multiple sclerosis management.
Conflict of interest statement
I.V. and C.S. declare no conflict of interest. S.M. received lecture fees and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi- Aventis, Chugai Pharma, QuintilesIMS and Teva. He received research grants from: Bundesministerium für Bildung und Forschung (BMBF), Deutsche Forschungsgesellschaft (DFG), Else-Kröner-Fresenius-Stiftung, Deutscher Akademischer Austauschdienst, Hertie Stiftung, Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Münster, Deutsche Stiftung Neurologie und Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, Merck Serono, Novartis, ONO Pharma, Roche and Teva. R.H.W.F., F.R. and J.N. are members of the DIU, which hosts the program. T.Z. received personal compensation from Biogen, Bayer, Celgene, Novartis, Roche, Sanofi and Teva for consulting services and additional financial support for the research activities from Bayer, BAT, Biogen, Novartis, Teva and Sanofi.
Figures







References
-
- Multiple Sklerose Management (M.Sc.) [(accessed on 23 July 2021)]; Available online: https://www.di-uni.de/studium-weiterbildung/medizin/ms-management.
-
- Postgraduate Study: Neuroscience and Neurodegeneration. [(accessed on 23 July 2021)]; Available online: https://www.sheffield.ac.uk/postgraduate/taught/courses/2021/neuroscienc....
-
- Master in Neuroimmunology 2021. [(accessed on 23 July 2021)]; Available online: https://www.cem-cat.org/en/corse/master-neuroimmunology.
-
- MAS Neurophysiotherapie—Fachexperte/Fachexpertin in Multiple Sklerose, Morbus Parkinson und Stroke. [(accessed on 23 July 2021)]; Available online: https://advancedstudies.unibas.ch/studienangebot/kurs/mas-neurophysiothe....
LinkOut - more resources
Full Text Sources